NZ603531A - Alcohol-resistant formulations - Google Patents
Alcohol-resistant formulationsInfo
- Publication number
- NZ603531A NZ603531A NZ603531A NZ60353111A NZ603531A NZ 603531 A NZ603531 A NZ 603531A NZ 603531 A NZ603531 A NZ 603531A NZ 60353111 A NZ60353111 A NZ 60353111A NZ 603531 A NZ603531 A NZ 603531A
- Authority
- NZ
- New Zealand
- Prior art keywords
- gums
- dosage form
- carboxymethylcellulose
- alcohol
- resistance
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 229920002125 Sokalan® Polymers 0.000 abstract 2
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 2
- 239000004034 viscosity adjusting agent Substances 0.000 abstract 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 abstract 1
- 244000215068 Acacia senegal Species 0.000 abstract 1
- 244000247812 Amorphophallus rivieri Species 0.000 abstract 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 abstract 1
- 241000416162 Astragalus gummifer Species 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 244000303965 Cyamopsis psoralioides Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 229920000084 Gum arabic Polymers 0.000 abstract 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 229920002752 Konjac Polymers 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 229920001615 Tragacanth Polymers 0.000 abstract 1
- 235000010489 acacia gum Nutrition 0.000 abstract 1
- 239000000205 acacia gum Substances 0.000 abstract 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 235000010418 carrageenan Nutrition 0.000 abstract 1
- 239000000679 carrageenan Substances 0.000 abstract 1
- 229920001525 carrageenan Polymers 0.000 abstract 1
- 229940113118 carrageenan Drugs 0.000 abstract 1
- 239000007931 coated granule Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000013265 extended release Methods 0.000 abstract 1
- 235000013312 flour Nutrition 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- -1 gums (e.g. Polymers 0.000 abstract 1
- 229940127022 high-dose drug Drugs 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000252 konjac Substances 0.000 abstract 1
- 235000010485 konjac Nutrition 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 239000001814 pectin Substances 0.000 abstract 1
- 235000010987 pectin Nutrition 0.000 abstract 1
- 229920001277 pectin Polymers 0.000 abstract 1
- 239000004584 polyacrylic acid Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 235000010413 sodium alginate Nutrition 0.000 abstract 1
- 239000000661 sodium alginate Substances 0.000 abstract 1
- 229940005550 sodium alginate Drugs 0.000 abstract 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 abstract 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33352110P | 2010-05-11 | 2010-05-11 | |
| PCT/US2011/035767 WO2011143118A2 (en) | 2010-05-11 | 2011-05-09 | Alcohol-resistant formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ603531A true NZ603531A (en) | 2014-08-29 |
Family
ID=44344024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ603531A NZ603531A (en) | 2010-05-11 | 2011-05-09 | Alcohol-resistant formulations |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20130202705A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2568969A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5894720B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN102883713B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2011253216B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2798700C (cg-RX-API-DMAC10.html) |
| IL (1) | IL222637A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2012013021A (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ603531A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2011143118A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012345659B2 (en) | 2011-12-02 | 2017-09-28 | Synchroneuron Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| CN103893146A (zh) * | 2012-12-25 | 2014-07-02 | 天津药物研究院 | 含福多司坦缓释剂型 |
| WO2014197744A1 (en) * | 2013-06-05 | 2014-12-11 | Synchroneuron, Inc. | Acamprosate formulations, methods of using the same, and combinations comprising the same |
| US9561187B1 (en) * | 2014-02-03 | 2017-02-07 | CMAX Technologies, Inc. | Sustained release metoprolol formulations |
| PL3164117T3 (pl) | 2014-07-03 | 2024-03-11 | SpecGx LLC | Preparaty zapewniające natychmiastowe uwalnianie i powstrzymujące przed nadużywaniem, zawierające polisacharydy inne niż celuloza |
| WO2017058869A1 (en) | 2015-09-29 | 2017-04-06 | Acorda Therapeutics, Inc. | Sustained release compositions of 4-aminopyridine |
| WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
| AR113993A1 (es) | 2017-12-21 | 2020-07-08 | Faes Farma Sa | Formulación una vez al día de hidrosmina |
| CN110812337B (zh) * | 2018-08-08 | 2022-04-12 | 上海宣泰医药科技股份有限公司 | 一种通过流化床制粒法制备氨基己酸片剂的方法 |
| CN110812332B (zh) * | 2018-08-10 | 2022-09-02 | 北京普德康利医药科技发展有限公司 | 一种双氯芬酸钠咽部滞留颗粒 |
| WO2020068510A1 (en) | 2018-09-25 | 2020-04-02 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
| US5223264A (en) | 1989-10-02 | 1993-06-29 | Cima Labs, Inc. | Pediatric effervescent dosage form |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| EP1689373B1 (en) * | 2003-10-10 | 2019-04-03 | Ethypharm | Sustained-release microgranules containing ginkgo biloba extract and the process for manufacturing these |
| US20070092573A1 (en) * | 2005-10-24 | 2007-04-26 | Laxminarayan Joshi | Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| EP1957052A2 (en) * | 2005-10-25 | 2008-08-20 | Pharmascience Inc. | A gastric retention drug delivery system |
| US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
| JP2008007293A (ja) * | 2006-06-30 | 2008-01-17 | Komori Corp | 搬送装置 |
| US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
| HUE032012T2 (en) * | 2007-09-13 | 2017-08-28 | Cima Labs Inc | Anti-Abuse Drug Products |
-
2011
- 2011-05-09 AU AU2011253216A patent/AU2011253216B2/en not_active Ceased
- 2011-05-09 WO PCT/US2011/035767 patent/WO2011143118A2/en not_active Ceased
- 2011-05-09 MX MX2012013021A patent/MX2012013021A/es unknown
- 2011-05-09 EP EP11720686A patent/EP2568969A2/en not_active Withdrawn
- 2011-05-09 CN CN201180023415.5A patent/CN102883713B/zh not_active Expired - Fee Related
- 2011-05-09 CA CA2798700A patent/CA2798700C/en not_active Expired - Fee Related
- 2011-05-09 JP JP2013510207A patent/JP5894720B2/ja not_active Expired - Fee Related
- 2011-05-09 NZ NZ603531A patent/NZ603531A/en not_active IP Right Cessation
- 2011-05-09 US US13/719,952 patent/US20130202705A1/en not_active Abandoned
-
2012
- 2012-10-23 IL IL222637A patent/IL222637A/en active IP Right Grant
-
2019
- 2019-01-03 US US16/239,222 patent/US20190133924A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012013021A (es) | 2012-12-17 |
| US20130202705A1 (en) | 2013-08-08 |
| US20190133924A1 (en) | 2019-05-09 |
| JP2013526521A (ja) | 2013-06-24 |
| JP5894720B2 (ja) | 2016-03-30 |
| WO2011143118A2 (en) | 2011-11-17 |
| WO2011143118A3 (en) | 2012-07-05 |
| CN102883713B (zh) | 2016-08-03 |
| AU2011253216A1 (en) | 2012-11-29 |
| CA2798700A1 (en) | 2011-11-17 |
| IL222637A (en) | 2017-04-30 |
| CN102883713A (zh) | 2013-01-16 |
| AU2011253216B2 (en) | 2016-10-20 |
| CA2798700C (en) | 2018-08-21 |
| EP2568969A2 (en) | 2013-03-20 |
| IL222637A0 (en) | 2012-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ602075A (en) | Abuse-resistant formulations | |
| MX2012013021A (es) | Formulaciones resistentes a alcohol. | |
| JP2013514386A5 (cg-RX-API-DMAC10.html) | ||
| MY165149A (en) | Use of binders for manufacturing storage stable formulations | |
| PH12013500289A1 (en) | Nalbuphine-based formulations and uses thereof | |
| TW200806338A (en) | Pharmaceutical formulations | |
| MY151240A (en) | Solid pharmaceutical formulations comprising bibw 2992 | |
| NZ608239A (en) | Aqueous drug delivery system comprising off - flavor masking agent | |
| WO2012040623A3 (en) | Nanostructured gels capable of controlled release of encapsulated agents | |
| EP3492069A3 (en) | Pharmaceutical compositions | |
| MX363495B (es) | Proceso de manufacturacion de una forma de dosificacion multifasica de rapida disolucion liofilizada. | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| JP2011241218A5 (cg-RX-API-DMAC10.html) | ||
| PH12015500823A1 (en) | Modified release formulations for oprozomib | |
| PH12014502856A1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
| PT2389070E (pt) | Formulações desintegráveis de carbonato de lantânio | |
| JP2015120758A5 (cg-RX-API-DMAC10.html) | ||
| WO2012055947A3 (de) | Herstellung orodispersibler filme | |
| EP2460540A4 (en) | MEDICAMENTAL ADMINISTRATIVE AGENT OF GENETICALLY MODIFIED GELATINS | |
| JP2017520619A5 (cg-RX-API-DMAC10.html) | ||
| MX2012013023A (es) | Formas de dosificacion de liberacion prolongada resistentes ala alcohol y que comprenden venlafaxina. | |
| WO2015011653A9 (en) | pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM | |
| HK1182013A (en) | Alcohol-resistant formulations | |
| WO2011128631A3 (en) | Vegetarian oral pharmaceutical and nutraceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 MAY 2016 BY DENNEMEYER + CO Effective date: 20150423 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 MAY 2017 BY DENNEMEYER + CO Effective date: 20160422 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 MAY 2018 BY DENNEMEYER + CO Effective date: 20170427 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 MAY 2019 BY DENNEMEYER + CO Effective date: 20180423 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 09 MAY 2020 BY DENNEMEYER + CO. Effective date: 20190419 |
|
| LAPS | Patent lapsed |